145 related articles for article (PubMed ID: 33457082)
1. Discovery of immunogenic cell death-inducing ruthenium-based photosensitizers for anticancer photodynamic therapy.
Konda P; Lifshits LM; Roque JA; Cole HD; Cameron CG; McFarland SA; Gujar S
Oncoimmunology; 2020 Dec; 10(1):1863626. PubMed ID: 33457082
[TBL] [Abstract][Full Text] [Related]
2. NIR-Absorbing Ru
Lifshits LM; Roque JA; Cole HD; Thummel RP; Cameron CG; McFarland SA
Chembiochem; 2020 Dec; 21(24):3594-3607. PubMed ID: 32761725
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the mechanisms of action and subcellular localization of ruthenium(II)-based photosensitizers.
Mo J; Mai Le NP; Priefer R
Eur J Med Chem; 2021 Dec; 225():113770. PubMed ID: 34403979
[TBL] [Abstract][Full Text] [Related]
4. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.
Heinemann F; Karges J; Gasser G
Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879
[TBL] [Abstract][Full Text] [Related]
5. Strained ruthenium complexes are potent light-activated anticancer agents.
Howerton BS; Heidary DK; Glazer EC
J Am Chem Soc; 2012 May; 134(20):8324-7. PubMed ID: 22553960
[TBL] [Abstract][Full Text] [Related]
6. Photobiomodulation combined with photodynamic therapy using ruthenium phthalocyanine complexes in A375 melanoma cells: Effects of nitric oxide generation and ATP production.
Negri LB; Martins TJ; da Silva RS; Hamblin MR
J Photochem Photobiol B; 2019 Sep; 198():111564. PubMed ID: 31382090
[TBL] [Abstract][Full Text] [Related]
7. Ruthenium(II) complexes as bioorthogonal two-photon photosensitizers for tumour-specific photodynamic therapy against triple-negative breast cancer cells.
Lin M; Zou S; Liao X; Chen Y; Luo D; Ji L; Chao H
Chem Commun (Camb); 2021 May; 57(36):4408-4411. PubMed ID: 33949487
[TBL] [Abstract][Full Text] [Related]
8. Ruthenium(II) polypyridyl complexes as mitochondria-targeted two-photon photodynamic anticancer agents.
Liu J; Chen Y; Li G; Zhang P; Jin C; Zeng L; Ji L; Chao H
Biomaterials; 2015 Jul; 56():140-53. PubMed ID: 25934287
[TBL] [Abstract][Full Text] [Related]
9. A Half-Sandwich Ruthenium(II) (N^N) Complex: Inducing Immunogenic Melanoma Cell Death in Vitro and in Vivo.
Xu Z; Xu M; Wu X; Guo S; Tian Z; Zhu D; Yang J; Fu J; Li X; Song G; Liu Z; Song X
ChemMedChem; 2023 Aug; 18(16):e202300131. PubMed ID: 37226330
[TBL] [Abstract][Full Text] [Related]
10. Ruthenium(II)-Arene Curcuminoid Complexes as Photosensitizer Agents for Antineoplastic and Antimicrobial Photodynamic Therapy: In Vitro and In Vivo Insights.
Marras E; Balacchi CJ; Orlandi V; Caruso E; Brivio MF; Bolognese F; Mastore M; Malacarne MC; Rossi M; Caruso F; Vivona V; Ferrario N; Gariboldi MB
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005258
[TBL] [Abstract][Full Text] [Related]
11. Ru(II)-Cyanine Complexes as Promising Photodynamic Photosensitizers for the Treatment of Hypoxic Tumours with Highly Penetrating 770 nm Near-Infrared Light.
Gandioso A; Izquierdo-García E; Mesdom P; Arnoux P; Demeubayeva N; Burckel P; Saubaméa B; Bosch M; Frochot C; Marchán V; Gasser G
Chemistry; 2023 Nov; 29(61):e202301742. PubMed ID: 37548580
[TBL] [Abstract][Full Text] [Related]
12. Red-Light-Responsive Ru Complex Photosensitizer for Lysosome Localization Photodynamic Therapy.
He G; Xu N; Ge H; Lu Y; Wang R; Wang H; Du J; Fan J; Sun W; Peng X
ACS Appl Mater Interfaces; 2021 May; 13(17):19572-19580. PubMed ID: 33900720
[TBL] [Abstract][Full Text] [Related]
13. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.
Wang L; Yin H; Jabed MA; Hetu M; Wang C; Monro S; Zhu X; Kilina S; McFarland SA; Sun W
Inorg Chem; 2017 Mar; 56(6):3245-3259. PubMed ID: 28263079
[TBL] [Abstract][Full Text] [Related]
14. A Novel Near-IR Absorbing Ruthenium(II) Complex as Photosensitizer for Photodynamic Therapy and its Cetuximab Bioconjugates.
Martínez-Alonso M; Gandioso A; Thibaudeau C; Qin X; Arnoux P; Demeubayeva N; Guérineau V; Frochot C; Jung AC; Gaiddon C; Gasser G
Chembiochem; 2023 Aug; 24(15):e202300203. PubMed ID: 37017905
[TBL] [Abstract][Full Text] [Related]
15. A lysosome-targeted ruthenium(II) polypyridyl complex as photodynamic anticancer agent.
Chen J; Tao Q; Wu J; Wang M; Su Z; Qian Y; Yu T; Wang Y; Xue X; Liu HK
J Inorg Biochem; 2020 Sep; 210():111132. PubMed ID: 32569884
[TBL] [Abstract][Full Text] [Related]
16. Rational design of type I photosensitizers based on Ru(ii) complexes for effective photodynamic therapy under hypoxia.
Liu X; Li G; Xie M; Guo S; Zhao W; Li F; Liu S; Zhao Q
Dalton Trans; 2020 Aug; 49(32):11192-11200. PubMed ID: 32748922
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Medicinal Potential of Two Ruthenium(II) Polypyridine Complexes as One- and Two-Photon Photodynamic Therapy Photosensitizers.
Hess J; Huang H; Kaiser A; Pierroz V; Blacque O; Chao H; Gasser G
Chemistry; 2017 Jul; 23(41):9888-9896. PubMed ID: 28509422
[TBL] [Abstract][Full Text] [Related]
18. Towards Ruthenium(II)-Rhenium(I) Binuclear Complexes as Photosensitizers for Photodynamic Therapy.
Wang Y; Felder PS; Mesdom P; Blacque O; Mindt TL; Cariou K; Gasser G
Chembiochem; 2023 Oct; 24(19):e202300467. PubMed ID: 37526951
[TBL] [Abstract][Full Text] [Related]
19. Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives.
Lee SY; Kim CY; Nam TG
Drug Des Devel Ther; 2020; 14():5375-5392. PubMed ID: 33299303
[TBL] [Abstract][Full Text] [Related]
20. Mitochondria-targeted ruthenium(II) complexes for photodynamic therapy and GSH detection in living cells.
Zhang W; Chen W; Fu F; Li MJ
Dalton Trans; 2024 Mar; 53(13):5957-5965. PubMed ID: 38456809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
